NIH #5R01CA207972-04
Functional Characterization of Glioma GWAS Variants
- Amount
- $584K
- Period
- 2016-08-23 → 2022-01-25
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF SOUTHERN CALIFORNIA
Glioma Diagnosis and Treatment · Genetics
10 total · 0 active
NIH #5R01CA207972-04
Awarded at UNIVERSITY OF SOUTHERN CALIFORNIA
NIH #5R01CA207972-03
Awarded at UNIVERSITY OF SOUTHERN CALIFORNIA
NIH #5R01CA207972-02
Awarded at UNIVERSITY OF SOUTHERN CALIFORNIA
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
Taletrectinib in <i>ROS1</i> + Non–Small Cell Lung Cancer: TRUST
Journal of Clinical Oncology · 2025-04-03 · 46 citations
188O: Patient-reported outcomes (PROs) with perioperative durvalumab in resectable NSCLC (AEGEAN)
Journal of Thoracic Oncology · 2025-03-01 · 1 citations
Journal of Thoracic Oncology · 2024-10-01 · 4 citations